業績

Karino K, Kono M, Kanda M, Atsumi T.

Reply.

Arthritis Rheumatol. in press.

IF=15.483

Kato M, Ninagawa K, Atsumi T.

Comment on: Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot study: Reply.

Rheumatology (Oxford). in press

IF=7.046

Aso K, Fujieda Y, Atsumi T.

Homonymous hemianopsia and headache with mass-like lesion Annals of the Rheumatic Diseases.

IF 19.103

Scherlinger M, Pan W, Hisada R, Boulougoura A, Yoshida N, Vukelic M, Umeda M, Krishfield S, Tsokos MG, Tsokos GC.

Phosphofructokinase P fine-tunes T regulatory cell metabolism, function, and stability in systemic autoimmunity.

Sci Adv. 2022;8(48):eadc9657.

IF = 14.980

Oe Y, Nomoto H, Nakamura A, Kuwabara S, Takahashi Y, Yasui A, Izumihara R, Miya A, Kameda H, Cho KY, Atsumi T, Miyoshi H.

Effect of beta-cell function on glucose variability when switching from insulin degludec plus a dipeptidyl peptidase-4 inhibitor to insulin degludec/liraglutide: preliminary results from a pilot study Int J Endocrinol, in press.

IF：2.803

Nagasaka K, Amano K, Dobashi H, Nagafuchi H, Sada K, Komagata Y, Yamamura M, Kato M, Endo T, Nakaya I, Takeuchi T, Murakawa Y, Sugihara T, Saito M, Hayashi T, Furuta S, Tamura N, Karasawa K, Banno S, Endo S, Majima M, Kaname S, Arimura Y, Harigai M.

Nation-wide Cohort Study of Remission Induction Therapy using Rituximab in Japanese patients with ANCA-Associated Vasculitis:

effectiveness and safety in the first six months.

Modern Rheumatology. in press.

IF: 2.862

Abe N, Kono Michihiro, Kono Michihito*, Katsuyama T, Ohmura K, Sato T, Karino K, Fujieda Y, Kato M, Hasebe R, Murakami M, and Atsumi T.

Cytokine and chemokine multiplex analysis-based exploration for potential treatment and prognostic prediction in large-vessel

vasculitis: a preliminary observational study. Frontiers in Immunology in press

IF=8.786

第32回日本リウマチ学会北海道・東北支部学術集会　若手リウマチ医奨励賞受賞者セッション　優秀賞　鎌田　和郎先生

Ninagawa K, Kato M, Tsuneta S, Ishizaka S, Ujiie H, Hisada R, Kono M, Fujieda Y, Ito YM, Atsumi T. Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot study.

Rheumatology (Oxford), in press

IF：7.046　

‘Development of ANCA-associated vasculitis followed by SARS-CoV-2 vaccination in a patient with HLA-DRB1*09: 01 allele‘ Takuro Kawamura, Daigo Nakazawa, Saori Nishio, Taiki Isozaki, Maki Komatsumoto, Tatsuya Atsumi.

Modern Rheumatology Case Reports, in press.

IF：2.862